Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11952426 Methods for treating multiple myeloma

Patent 11952426 was granted and assigned to Janssen Biotech on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Janssen Biotech

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119524260

Patent Inventor Names

Raluca Verona0

Shun xin Wang lin0

Suzette Girgis0

Tara Stephenson0

Homer Adams0

Arnob Banerjee0

Jenna Goldberg0

Date of Patent

April 9, 2024

Patent Application Number

173177890

Date Filed

May 11, 2021

Patent Citations

‌

US Patent 8236308 Composition comprising cross-species-specific antibodies and uses thereof

‌

US Patent 7994289 Humanized anti-CD3 antibodies

‌

US Patent 10072088 Anti-BCMA antibodies and uses thereof

Patent Primary Examiner

CPC Code

...

Patent abstract

Methods of treating cancers using a BCMAxCD3 bispecific antibody are described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11952426 Methods for treating multiple myeloma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API